|
|
|||
| |||||||||||||||||||||||||||||||||||||
Clinical research in developing countries has generated considerable discussion. Especially controversial are the use of a placebo instead of the best proven treatment as a control, and the availability of a test intervention after the trial. That such designs, which would be rejected in the developed world, have been carried out in developing countries has led some to accuse the researchers involved of exploitation and to propose banning such trials.
This controversy stimulated a seminar series in the National Institutes of Health's bioethics department, which in turn resulted in this collection of essays. The writing style is consistently concise, the
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |